UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
40 hedge funds and large institutions have $11.4M invested in Unity Biotechnology in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 5 closing their positions.
Holders
40
Holders Change
+3
Holders Change %
+8.11%
% of All Funds
0.54%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
8
Increased
9
Reduced
5
Closed
5
Calls
$480K
Puts
$275K
Net Calls
+$205K
Net Calls Change
+$156K
Top Buyers
Top Sellers
| 1 |
1
Alyeska Investment Group
Chicago,
Illinois
|
$304K |
| 2 |
2
Morgan Stanley
New York
|
$45.1K |
| 3 |
3
Jane Street
New York
|
$0 |
| 4 |
4
Squarepoint
New York
|
$0 |
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$2.34K |
